Expression of vascular endothelial growth factor in human periodontal tissues: Comparison of healthy and diabetic patients

Journal of Periodontology

Volumn 74, Issue 2, 2003, Pages 181-187

  Ünlü, Fusun ^a   Güneri, Pelin Gürdal ^b   Hekimgil, Mine ^c   Yeşilbek, Banu ^a   Boyacioǧlu, Hayal ^d  

^a EGE UNIVERSITY   (Turkey)

^b Dept of Oral Diagnosis/Radiology ^*  (Turkey)

^c Faculty of Medicine   (Turkey)

^d Faculty of Science   (Turkey)

Author keywords

Angiogenesis; Cells, endothelial; Diabetes mellitus; Growth factors, vascular endothelial; Periodontal Epidemiology

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; GINGIVA; HEALTH STATUS; HUMAN; HUMAN TISSUE; MACROPHAGE; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTITIS; PERIODONTIUM; PROTEIN EXPRESSION;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; NEOVASCULARIZATION, PATHOLOGIC; PERIODONTITIS; PERIODONTIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0344406164     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2003.74.2.181     Document Type: Article

References (52)

1. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267:10931-10934.
2. Carlile J, Harada K, Baillie R, et al. Vascular endothelial growth factor (VEGF) expression in oral tissues. Possible relevance to angiogenesis, tumour progression and field cancerisation. J Oral Pathol Med 2001;30:449-457.
3. Matsushita K, Motani R, Sauta T, et al. Lipopolysaccharide enhances the production of vascular endothelial growth factor by human pulp cells in culture. Infect Immun 1999;67:1633-1639.
4. Michi Y, Morita I, Amagasa T, Murota S. Human oral squamous cell carcinoma cell lines promote angiogenesis via expression of vascular endothelial growth factor and upregulation of KDR/flk-1 expression in endothelial cells. Oral Oncol 2000;36:81-88.
5. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, Di Pietro LA. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998;152:1445-1452.
6. Senger DR, Van De Water L, Brown L, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993;12:303-324.
7. Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993;91:2235-2243.
8. Taichman NS, Cruchley AT, Fletcher LM, et al. Vascular endothelial growth factor in normal human salivary glands and saliva. A possible role in the maintenance of mucosal hemostasis. Lab Invest 1998;78:869-875.
9. Johnson RB, Serio FG, Dai X. Vascular endothelial growth factors and progression of periodontal diseases. J Periodontol 1999;70:848-852.
10. Becit N, Ceviz M, Kocak H, et al. The effect of vascular endothelial growth factor on angiogenesis. An experimental study. Eur J Vasc Endovasc Surg 2001;22:310-316.
11. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-1039.
12. Ferrara N, Houck K, Jakeman L, Leung D. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992;13:18-32.
13. Lantieri LA, Martin-Garcia N, Wechsler J, Mitrofanoff M, Raulo Y, Baruch JP. Vascular endothelial growth factor expression in expanded tissue. A possible mechanism of angiogenesis in tissue expansion. Plastic Reconstruct Surg 1998;101:392-398.
14. Connolly DT. Vascular permeability factor. A unique regulator of blood vessel function. J Cell Biochem 1991; 47:219-223.
15. Nakagawa K, Chen YX, Ishibashi H, et al. Angiogenesis and its regulation. Roles of vascular endothelial cell growth factor. Semin Thromb Hemost 2000;26:61-66.
16. Sakuta T, Matsushita K, Yamaguchi N, et al. Enhanced production of vascular endothelial growth factor by human monocytic cells stimulated with endotoxin through transcription factor SP-1. J Med Microbiol 2001; 50:233-237.
17. Booth V, Young S, Cruchley A, Taichman NS, Paleolog E. Vascular endothelial growth factor in human periodontal disease. J Periodont Res 1998;33:491-499.
18. Chapple CC, Kumar RK, Hunter N. Vascular remodelling in chronic inflammatory periodontal disease. J Oral Pathol Med 2000;29:500-506.
19. Cornelini R, Artese L, Rubini C, et al. Vascular endothelial growth factor and microvessel density around healthy and failing dental implants. Int J Oral Maxillofac Implants 2001;16:398-393.
20. Oyama T, Sakuta T, Matsushita K, Mauyama I, Nagaoka S, Torii M. Effects of roxithromycine on tumor necrosis factor-alpha-induced vascular endothelial growth factor expression in human periodontal ligament cells in culture. J Periodontol 2000;71:1546-1553.
21. Yuan K, Jin YT, Lin MT. The detection and comparison of angiogenesis-associated factors in pyogenic granuloma by immunohistochemistry. J Periodontol 2000; 71:701-709.
22. Katz J. Elevated blood glucose levels in patients with severe periodontal disease. J Clin Periodontol 2001; 28:710-712.
23. Kinane DF, Marshall GJ. Periodontal manifestations of systemic disease. Aust Dent J 2001;46:2-12.
24. Moore PA, Weyant RJ, Mongelluzzo MB, et al. Type 1 diabetes mellitus and oral health. Assessment of periodontal disease. J Periodontol 1999;70:409-417.
25. Noack B, Jachmann I, Roscher S, et al. Metabolic diseases and their possible link to risk indicators of periodontitis. J Periodontol 2000;71:898-903.
26. Oliver RC, Tervonen T. Diabetes - a risk factor for periodontitis in adults. J Periodontol 1994;65:530-538.
27. Murrah VA. Diabetes mellitus and oral manifestations. J Oral Pathol 1985;14:271-281.
28. Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int 2000;77(Suppl.):113-119.
29. Endo M, Yanagisawa K, Tsuchida K, et al. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy. Horm Metab Res 2001;33:317-322.
30. Hernandez C, Burgos R, Canton A, Garcia-Arumi J, Segura RM, Simo R. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. A case-control study. Diabetes Care 2001;24:516-521.
31. Malamitsi-Puchner A, Sarandakou A, Tziotis J, Dafogianni C, Bartsocas CS. Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus. Pediatr Res 1998;44:873-875.
32. De Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 2001;12:993-1000.
33. Pinter E, Haigh J, Nagy A, Madri J. Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation. Am J Pathol 2001;158:1999-1206.
34. Santilli F, Spagnoli A, Mohn A, et al. Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of Type 1 diabetes during childhood at risk for developing persistent microalbuminuria. J Clin Endocrinol Metab 2001;86: 3871-3876.
35. Gerhardinger C, Brown LF, Roy S, Mizutani M, Zucker CL, Lorenzi M. Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. Am J Pathol 1998;152:1453-1462.
36. Lu M, Kroki M, Amano S, et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 1998;101:1219-1224.
37. Paques M, Massin P, Gaudric A. Growth factors and diabetic retinopathy. Diabetes Metab 1997;23:125-130.
38. De Vriese AS, Tilton RG, Stephan CC, Lameire NH. Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 2001; 12:1734-1741.
39. Lee HB, Chung SH, Chu WS, Kim JK, Ha H. Peritoneal dialysis in diabetic patients. Am J Kidney Dis 2001; 38:S200-S203.
40. American Academy of Periodontology. Parameters of Care. Chicago: American Academy of Periodontology; 1996.
41. Fenton C, Patel A, Dinauer C, Robie DK, Tuttle RM, Francis GL. The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults. Thyroid 2000;10:349-357.
42. Lennard CM, Patel A, Wilson J, et al. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer. Surgery 2001;129:552-558.
43. Ferrara N. Molecular and biological properties of the vascular endothelial growth factor. J Mol Med 1999; 77:527-543.
44. Emingil G, Darcan S, Keskinoglu A, Kutukculer N, Atilla G. Localized aggressive periodontitis in a patient with Type 1 diabetes mellitus. A case report. J Periodontol 2001;72:1265-1270.
45. Firatli E, Yilmaz O, Onan U. The relationship between clinical attachment loss and the duration of insulin-dependent diabetes mellitus (IDDM) in children and adolescence. J Clin Periodontol 1996;23:362-366.
46. Salvi GE, Lawrence HP, Offenbacher S, Beck JD. Influence of risk factors on the pathogenesis of periodontitis. Periodontol 2000 1997;14:173-201.
47. Tervonen T, Oliver RC. Long-term control of diabetes mellitus and periodontitis. J Clin Periodontol 1993;20: 431-435.
48. Thorstensson H, Hugoson A. Periodontal disease experience in adult long-duration insulin dependent diabetics. J Clin Periodontol 1993;20:352-358.
49. Miller LS, Manwell MA, Newbold D, et al. The relationship between reduction in periodontal inflammation and diabetes control. A report of nine cases. J Periodontol 1992;63:843-848.
50. Chiarelli F, Santilli F, Mohn A. Role of growth factors in the development in diabetic complications. Horm Res 2000;53:53-67.
51. Stehouwer CD, Lambert J, Donker AJ, van Hinsberg VW. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997;34:55-68.
52. Waltenberger J. Impaired collateral vessel development in diabetes. Potential cellular mechanisms and therapeutic implications. Cardiovasc Res 2001;49:554-560.